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Neurogenesis in mammals occurs throughout life in two brain regions: the ventricular–subventricular
zone (V–SVZ) and the subgranular zone (SGZ) of the hippocampal dentate gyrus. Development andAvailable online 19 January 2016
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regulation of the V–SVZ and SGZ is unique to each brain region, but with several similar characteristics.
Alterations to the production of new neurons in neurogenic regions have been linked to psychiatric and
neurodegenerative disorders. Decline in neurogenesis in the SGZ correlates with affective and psychiatric
disorders, and can be reversed by antidepressant and antipsychotic drugs. Likewise, neurogenesis in the
V–SVZ can also be enhanced by antidepressant drugs. The regulation of neurogenesis by neuro-
transmitters, particularly monoamines, in both regions suggests that aberrant neurotransmitter signaling
observed in psychiatric disease may play a role in the pathology of these mental health disorders. Si-
milarly, the cognitive deﬁcits that accompany neurodegenerative disease may also be exacerbated by
decreased neurogenesis. This review explores the regulation and function of neural stem cells in rodents
and humans, and the involvement of factors that contribute to psychiatric and cognitive deﬁcits.
This article is part of a Special Issue entitled SI:StemsCellsinPsychiatry.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
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Neurogenesis is the process of producing new neurons from
neural stem cells (NSCs). In most brain regions, this process is
restricted to a limited period during development, and endsB.V. This is an open access article u
.shortly after birth (Gotz and Huttner, 2005; Ming and Song, 2011;
Taverna et al., 2014). However, neurogenesis is observed well into
the postnatal period and throughout adulthood primarily in two
discrete brain regions: the subgranular zone (SGZ) of the dentate
gyrus and the ventricular–subventricular zone (V–SVZ), which
lines the lateral wall of the lateral ventricles. The process of neu-
rogenesis has been linked behaviorally and biochemically to psy-
chiatric disorders such as major depression, schizophrenia, andnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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are commonly linked to psychiatric disorders, and neurogenesis is
thought to be required for a therapeutic response to anti-
depressant treatment. However, neural stem cells in the V–SVZ
have also displayed changes in function and number in psychiatric
disease, age, and with increased stress levels, which are often a
precipitating factor in the onset of psychiatric disorders. NSCs have
been shown to respond to treatment with antidepressant and
atypical antipsychotic drugs, which can rescue diminished neu-
rogenesis. The functional implications of decreased neurogenesis
in psychiatric disease, as well as the therapeutic implications of
rescuing neurogenesis with interventions, remain unclear. The
emerging links between neurogenesis and mental health disorders
support the idea that neurogenic therapies may one day enhance
less effective treatments for patients suffering from major de-
pression, schizophrenia, cognitive decline, and neurodegeneration.
Here, we provide an overview of neurogenesis in the SGZ and V–
SVZ, and explore the current literature on the relationship be-
tween psychiatric disorders, therapeutics, and adult neurogenesis.2. Neural stem cell developmental origins and lineage
Much of our understanding of adult NSC biology has come from
studies in rodents, which have shown that NSCs in the SGZ and the
V–SVZ share many similarities but are two distinct populations of
cells that differ signiﬁcantly in their development, organization,
and function. NSCs from both the V–SVZ and SGZ are astrocyte-like
cells with morphological similarity to mature glia, express mole-
cular markers common to astrocytes, including glial ﬁbrillary
acidic protein (GFAP) and are mostly quiescent (Alvarez-Buylla
et al., 2001; Laywell et al., 2000; Merkle et al., 2004; Noctor et al.,
2002). In the V–SVZ, these NSCs are referred to as type B cells that,
upon activation, upregulate epidermal growth factor receptor
(EGFR) and the progenitor marker Nestin and divide to give rise to
type C transit amplifying cells which in turn give rise to type A
neuroblasts. Neuroblasts then exit the V–SVZ and undergo ex-
tensive migration through the rostral migratory stream to arrive at
the olfactory bulb, where they mature into GABAeric interneurons,
many of which also express dopamine (Alvarez-Buylla et al., 2001;
Doetsch and Alvarez-Buylla, 1996; Doetsch et al., 1997; Ming and
Song, 2011). The spatial organization of these newborn neurons in
the olfactory bulb is dependent upon the location of their origin in
the V–SVZ, and NSCs originating from different V–SVZ micro-
domains produce interneuron populations with distinct molecular
markers in the olfactory bulb (Merkle et al., 2014). NSCs also give
rise to oligodendrocytes and astrocytes (Doetsch et al., 2002; Lois
and Alvarez-Buylla, 1993; McKay, 1997; Merkle et al., 2004) how-
ever the lineage for these cells is less clear. NSCs are tightly
regulated by the niche which in the V–SVZ is bordered on one side
by ciliated ependymal cells lining the lateral ventricle and on the
striatal side by a vast vascular plexus. Type B NSCs span these two
compartments sending an apical process through the ependymal
layer into the lateral ventricle and a basal process contacting blood
vessels which allows NSCs to receive molecular signals from cer-
ebrospinal ﬂuid (Kokovay et al., 2012; Sawamoto et al., 2006),
ependymal cells (Lim et al., 2000) and the vasculature (Delgado
et al., 2014; Kokovay et al., 2010; Shen et al., 2008; Tavazoie et al.,
2008). In addition to type B NSCs, microglia, niche astrocytes, type
C, and type A cells are closely assembled in the V–SVZ niche be-
tween the vasculature and ependymal layer.
In the hippocampus, type 1 NSCs are mostly quiescent, with
their cell bodies in the SGZ and processes extending through the
granular cell layer, and a tangential process extending through the
border of the hilus and the granular cell layer similar to radial glia
(Seri et al., 2004). Two sex determining region Y-box 2 (Sox-2)þpopulations of progenitor cells are present in the hippocampus: a
quiescent radial glia-like subpopulation expressing GFAP, nestin,
and brain-lipid binding protein (BLBP), and a non-radial glia-like
subpopulation that is more proliferative and lacks the markers
associated with radial glia (Suh et al., 2007). Once activated, NSCs
divide asymmetrically, giving rise to a type 2 daughter cell. type
2 cells are amplifying neural progenitor cells that lack the GFAP
expression of the type 1 mother cell, but retain expression of
Nestin (Encinas et al., 2006; Filippov et al., 2003; Kempermann
et al., 2004). These progenitor cells proliferate in close association
with astrocytes and the vasculature in the SGZ (Ashton et al., 2012;
Palmer et al., 2000). Type 2 cells continue to divide on average
2.3 times before maturing into doublecortin-positive type 3 neu-
roblasts (Encinas et al., 2011). Neuroblasts mature into granule
cells after migrating a short distance into the granular layer of the
dentate gyrus. In the granule cell layer, neuroblasts fully mature
into glutamatergic granule neurons and receive glutamatergic and
GABAergic innervation from the entorhinal cortex while sending
outputs to the CA3 pyramidal cell layer through the mossy ﬁber
pathway (Ming and Song, 2011; van Praag et al., 2002; Zhao et al.,
2006).
Lineage tracing studies have revealed that V–SVZ NSCs are
derived during development from striatal radial glia. The labeled
radial glia in murine neonates were observed to give rise to neu-
rons, oligodendrocytes, and astrocytes in the V–SVZ. Lineage tra-
cing also identiﬁed radial glia to be the origin of type B and type C
cells in the adult, thus establishing striatal radial glia as the neo-
natal origin of V–SVZ NSCs (Merkle et al., 2004). In contrast, the
origin of NSCs in the SGZ is a population of Hedgehog-responsive
cells from embryonic day 15.5–17.5 in the ventral hippocampus
which migrate to the ventral and dorsal DG and are established in
this region by postnatal day 15 (Li et al., 2013). Descendants de-
rived from these hedgehog-responsive cells maintain their NSC
characteristics and contribute to neurogenesis in the adult. Em-
bryonic neurogenesis and development are functionally distinct
from adult hippocampal neurogenesis. Adult hippocampal neuro-
genesis is thought to be activity-dependent, and is established
during adolescence in the rodent brain prior to sexual maturity
(Nicola et al., 2015). The timing of onset for adult neurogenesis
markers in the rodent hippocampus correlates with the time when
activity- and experience- dependent neurogenesis becomes cri-
tical for learning, memory, and affective- related development.3. Factors regulating neurogenesis
NSCs are highly responsive to environmental molecular cues,
which help in the establishment of the niche in embryos/neonates
while maintaining the neurogenic functions of the niche in the
adult. The vasculature is a major regulator of NSC proliferation,
migration, and differentiation. Elegant studies using an in vitro
model established that secreted factors from the vasculature in-
crease NSC self-renewal and neuron production (Shen et al., 2004).
Furthermore, 3-dimensional mapping of the V–SVZ niche showed
that proliferating type B and type C cells are preferentially asso-
ciated with the vasculature (Shen et al., 2008; Tavazoie et al.,
2008). How this association is maintained is not clear, however,
disruption of integrin-α6 results in aberrant proliferation (Shen
et al., 2008), suggesting that laminin–integrin interaction is re-
quired. We previously demonstrated that vascular secretion of the
chemokine stromal derived factor-1 (SDF-1) is required for neu-
rosphere-expanded NSCs to home to the vasculature. This ex-
periment utilized transplantation of adult-derived V–SVZ NSCs
transduced with shRNA against the SDF-1 chemokine receptor
CXCR4 into naïve adult V–SVZ (Kokovay et al., 2010). The results of
this study suggest SDF-1 may play a role as a chemoattractant to
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shown to secrete neurotrophin-3 (NT-3), which upon uptake by
NSCs, induces the phosphorylation of endothelial nitric oxide
synthase (eNOS) and thus increases nitric oxide (NO) production
within B cells. NO reduces the cycling of B cells, therefore reg-
ulating NSC proliferation and quiescence (Delgado et al., 2014). CSF
and ependymal cells have also been implicated in NSC function.
Movement of CSF directs migration of neuroblasts (Sawamoto
et al., 2006). Ependymal cell secretion of noggin inhibits bone
morphogenic protein (BMP) signaling in type B cells, preventing
glial differentiation and allowing production of type C cells (Lim
et al., 2000), although others have found that noggin blocks neu-
rogenesis while promoting oligodendrogliogenesis (Colak et al.,
2008). It should be noted that these discrepant results may be due
to differences in methodology, as Lim and co-workers utilized an
in vitro model for noggin antagonism of BMPs while Colak et al
directly tested exogenous noggin in vivo. We have shown that the
close association between type B cells and ependymal cells re-
quires the adhesion molecule vascular cell adhesion molecule 1
(VCAM1), which is expressed on the apical process of type B cells
anchoring NSCs to the ependymal layer and allowing signaling
between cerebrospinal ﬂuid (CSF) and type B cell processes.
Blockade of VCAM1 results in aberrant proliferation and eventual
depletion of the stem cell pool (Kokovay et al., 2012). Other im-
portant environmental cues come from growth factors such as
epidermal growth factor (EGF), and other EGF Receptor (EGFR)
ligands (i.e. TGF (Seroogy et al., 1993; Tropepe et al., 1997)) and
ﬁbroblast growth factor (FGF) in the CSF, which stimulate pro-
liferation of type C cells in vivo and stimulates neurosphere pro-
duction in vitro (Doetsch et al., 2002; Kuhn et al., 1997; Reynolds
et al., 1992). Type C cells become proliferative and migratory in the
presence of EGF. Furthermore, EGF confers multipotency in type C
cells, which can give rise to neurons, astrocytes and oligoden-
drocytes in vitro (Doetsch et al., 2002; Reynolds et al., 1992).
However, EGF does not increase neurogenesis in the olfactory bulb
in vivo (Kuhn et al., 1997). FGF induces proliferation in the V–SVZ
and increases the number of neuroblasts and levels of neurogen-
esis in the olfactory bulb (Kuhn et al., 1997). Vascular endothelial
growth factor (VEGF) has also been shown to promote prolifera-
tion in the V–SVZ, illustrating the necessity of vascular signals in
neurogenesis (Jin et al., 2002).
The function of NSCs in the SGZ is heavily inﬂuenced by en-
vironmental molecular cues. As in the V–SVZ, the vasculature in
the SGZ has strong effects on the proliferation of NSCs. Bursts of
endothelial cell division are commonly observed along with clus-
ters of increased neurogenesis (Palmer et al., 2000). The receptor
for VEGF colocalizes with these clusters of increased cell division.
Indeed, infusion of VEGF increases the number of doublecortinþ
neuroblasts, which express VEGF Receptor 2 (Jin et al., 2002).
Furthermore, treating postnatal day 16 cortical stem cell cultures
with VEGF increases neurogenesis. Although EGF and FGF do not
increase proliferation in the SGZ as observed in the V–SVZ, EGF
does favors the generation of astrocytes and reduces the number
of neuroblasts in the SGZ (Kuhn et al., 1997). Adrenal hormones
have also been shown to have strong effects on neurogenesis in
the SGZ. Adrenalectomized rats show an increase in the number of
GFAPþ labeled astrocytes and enolase labeled neurons in the SGZ.
However, replacement of corticosterone in these rats suppresses
proliferation (Gould et al., 1992). These results indicate that glu-
cocorticoids, such as corticosterone, negatively regulate neuro-
genesis and gliogenesis in the SGZ. The mechanism through which
glucocorticoids regulate neurogenesis in the SGZ may involve
N-methyl-D-aspartate receptors (NMDAR) and the excitatory ef-
fects of glutamate (Gould et al., 1997). Shh signaling has important
functions in maintaining the SGZ niche after development. The
loss of sonic hedgehog (Shh) or smoothened (Smo) results insevere deﬁciencies in the hippocampus, but without affecting the
early SGZ invasion of hedgehog responsive cells from the ventral
hippocampus. In turn, Shh signaling helps to retain more des-
cendants of the hedgehog responsive cells in the adult, thereby
contributing to the maintenance of the postnatal SGZ (Li et al.,
2013).4. Neurotransmitter regulation of neurogenesis
NSCs are highly inﬂuenced by monoaminergic neuro-
transmitters. Two neurotransmitter in particular are common
targets for psychiatric pharmacological therapies: dopamine (DA)
and serotonin (5-HT). These monoamines have been shown to
inﬂuence proliferation and neurogenesis within the adult brain
and these classical neuromodulators can have a profound effect on
neurogenesis as levels of monoaminergic neurotransmitters
change in the brain under conditions of psychiatric disease, age, or
neurodegeneration.
4.1. Neurotransmitter regulation of stem cells in the SGZ
SGZ NSCs are highly dependent upon serotonergic innervation
by projections from the raphe nuclei (Mongeau et al., 1997). Le-
sioned 5-HT projections from the raphe to the dentate gyrus de-
creases proliferation of progenitor cells (Brezun and Daszuta,
1999). Adult neurogenesis has been shown to be enhanced in mice
lacking the 5-HT transporter, a genetic manipulation that leads to
increased extracellular levels of 5-HT in the brain (Schmitt et al.,
2007). The 5-HT1A receptor is thought to mediate a bulk of the
neurogenic activity in the dentate gyrus. Depletion of 5-HT and
simultaneous activation of 5-HT1A receptors by 8-OH-DPAT results
in increased proliferation in the SGZ (Huang and Herbert, 2005).
Further, activation of 5-HT1A receptors alone has been reported to
increase proliferation (Santarelli et al., 2003) and blockade of
5-HT1A receptors in the dentate gyrus reduces proliferation of
progenitors (Radley and Jacobs, 2002). In schizophrenia, 5-HT1A
activation has been shown to improve cognitive symptoms and
promote neurogenesis (Schreiber and Newman-Tancredi, 2014;
Sumiyoshi et al., 2001). This 5-HT1A – mediated neurogenesis may
be due, in part, to the activation of this receptor on SGZ astrocytes,
which can regulate neurotrophic factor secretion (Aberg et al.,
2000; Manev et al., 2001; Whitaker-Azmitia et al., 1993). Agonism
of 5-HT2C receptors in the SGZ also produces an increase in neu-
rogenesis (Banasr et al., 2004). Other 5-HT receptor subtypes have
been identiﬁed in the SGZ, but their inﬂuence on neurogenesis in
this region is still under debate (Alenina and Klempin, 2015; Lucas
et al., 2007). The speciﬁc effects of 5-HT receptor activation is not
currently well characterized. Future studies will likely focus on
understanding which 5-HT receptor subtypes inﬂuence type 1,
type 2, and type 3 stem and progenitor cells, and on determining if
5-HT receptor activation produces a direct or indirect effect on
neurogenesis.
Inhibitory signaling from GABA has been shown to be a critical
regulator of neurogenesis in the dentate gyrus (Song et al., 2012).
Type 2 amplifying progenitor cells are activated by GABA, which
promotes activity-dependent differentiation of NSCs, likely
through a GABAA-dependent mechanism (Tozuka et al., 2005). This
GABA-mediated depolarization of progenitors in the subgranular
zone has been linked to the incorporation of AMPA receptors into
immature granule cells, a process necessary for learning and
memory formation (Chancey et al., 2013). Type 1 cells were found
to be sensitive to signaling via the GABAB receptor, where chronic
GABABR blockade increased neurogenesis in the subgranular zone
(Felice et al., 2012). Migration of progenitors in the dentate gyrus
is also GABA-dependent. Transgenic animals lacking the GABA α4
Table 1
Neurotransmitter regulation of neurogenesis in the SGZ.
5-HT ↑neurogenesis
5-HT1A ↑neurogenesis and proliferation
5-HT2C ↑neurogenesis
Other 5-HT receptors Disputed effects
GABAAR ↑differentiation
GABABR ↓neurogenesis
GABA α4 ↑migration into granular cell layer
GABA α2 ↓migration into granular cell layer
Table 2
Neurotransmitter regulation of neu-
rogenesis in the V–SVZ.
5HT ↑neurogenesis
5-HT1A ↑proliferation
5-HT2C ↑proliferation
5-HT1B ↓proliferation
DA ↑proliferation
D1-like receptors ↓proliferation
D2-like receptors ↑proliferation
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into the granular cell layer, while animals lacking the α2 subunit
displayed an increase in the number of neuroblasts that migrated
into the granular cell layer (Duveau et al., 2011). The role of GABA
in the dentate gyrus is heavily dependent upon receptor type and
subunit expression, conferring the capacity for differential mod-
ulation of hippocampal NSCs by GABA. It is well established that
stress and anxiety can modulate GABA receptor expression, and
these also alter neurogenesis (Earnheart et al., 2007). The speciﬁc
mechanisms by which different GABA receptor and subunit ar-
rangements alter SGZ neurogenesis are complicated and a com-
plete picture of GABA involvement in this process is currently
unavailable. However, GABA signaling plays an obvious role in
modulating readouts of neurogenesis, and given the pharmacolo-
gical tools immediately available for augmenting GABA function, a
greater understanding of the speciﬁcs of GABA signaling will likely
advance our ability to directly inﬂuence SGZ neurogenesis in the
adult brain. See Table 1 for a summary of the most prominent
neurotransmitter actions in the regulation of SGZ neurogenesis.
4.2. Neurotransmitter regulation of stem cells in the V–SVZ
The adult V–SVZ also receives serotonergic input from the ra-
phe nuclei (Brezun and Daszuta, 1999). Lesion studies in which the
serotonergic raphe nuclei inputs to the V–SVZ are ablated reveal a
decrease in neurogenesis (Banasr et al., 2004; Brezun and Daszuta,
1999). The serotonin (5-HT) receptor family contains a myriad of
5-HT receptors. Functionally, the 5-HT1A, 5-HT1B, 5-HT2C and
5-HT5A receptors have been demonstrated in the V–SVZ (Banasr
et al., 2004; Soumier et al., 2010; Tong et al., 2014). In these stu-
dies, agonism of the 5-HT1A and 5-HT2C receptors increase pro-
liferation of neural stem cells in the V–SVZ, while agonism of the
5-HT1B receptor resulted in a decline in proliferative activity (Ba-
nasr et al., 2004; Soumier et al., 2010). Supraependymal axons that
enervate the V–SVZ originate from the median and dorsal raphe.
These axons line the apical surface of the V–SVZ and make contact
directly on type B cells and ependymal cells. Lesion studies in
which the raphe nuclei inputs to the V–SVZ are ablated reveal a
decrease in neurogenesis. Infusion of 5-HT2C agonizts into the
lateral ventricles induces proliferation of type B cells, while the
antagonist induces the opposite effect reducing proliferation. Al-
though modulation of 5-HT2C signiﬁcantly affects type B cell pro-
liferation, type C and A cells remain unaffected (Tong et al., 2014).
The effects of serotonergic innervation on ependymal cells remain
to be studied, but 5-HT signaling might affect ependymal cell cilia,
as serotonin has been shown to increase cilia beating frequency on
ependymal cells in the brainstem of rats (Nguyen et al., 2001).
Serotonin is one of the primary neurotransmitters involved in
mood regulation and mood disorders. It is possible, therefore, that
changes in serotonin regulation seen with mood disorders may
also result in a decline in neurogenesis in the V–SVZ, although the
functional and behavioral implications of this in adults are not yet
clear.
The V–SVZ receives dopaminergic innervation from the sub-
stantia nigra (SNc) and ventral tegmental area (VTA) (Baker et al.,2004; Freundlieb et al., 2006; Hoglinger et al., 2004). Axonal
projections from the posterior SNc innervate the posterodorsal V–
SVZ while the anterior SNc projects axons to the anterior V–SVZ
and the rostral migratory stream (Hoglinger et al., 2014). The VTA
preferentially projects axons to the ventral V–SVZ (Hoglinger et al.,
2014). These dopaminergic projections contact type C progenitor
cells that express cognate D1-like and D2-like dopamine receptors
(Coronas et al., 2004; Hoglinger et al., 2004; Winner et al., 2009).
These G protein-coupled receptors are classically divided into two
groups based on their activity: D1-like (D1 and D5 receptors),
which activate adenylyl cyclase, and D2-like (D2, D3, and D4),
which inhibit adenylyl cyclase. In the developing brain, activation
of the D1 receptor on proliferating cells decreases proliferation of
progenitors by retarding the progression from G1 to S phase of the
cell cycle. However, activation of D2-like receptors enhanced
proliferation of progenitors by promoting the transition from G1 to
S phase (Ohtani et al., 2003). It is likely that a similar response
remains in the adult neural stem cell population of the V–SVZ.
In the adult brain, loss of dopaminergic signaling in the V–SVZ
has detrimental effects on neural stem cell proliferative capacity.
Lesion of dopaminergic inputs using 6-hydroxydopamine (6-
OHDA) or 1-methyl-4-pheynyl-1,2,3,6-tetrahydropyridine (MPTP)
produced a loss of tyrosine hydroxylase (TH)-positive dopami-
nergic projections to the V–SVZ, and a decline in neural stem cell
proliferation (Baker et al., 2004; Freundlieb et al., 2006; Hoglinger
et al., 2004; Winner et al., 2009). O’Keeffe and coworkers (O'Keeffe
et al., 2009) reveal a concomitant decline in EGF production in the
V–SVZ following dopaminergic lesion, and have demonstrated a
reversal of this deﬁcit through levodopa administration. This study
implies a critical role for dopamine in the V–SVZ as it appears to be
linked to expression of EGF, a major contributor to V–SVZ pro-
liferation (Craig et al., 1996; Reynolds et al., 1992). The sensitivity
of the V–SVZ neural stem cell population to treatment with levo-
dopa indicates a potential role for this region in psychiatric dis-
ease. See Table 2 for a summary of the most prominent neuro-
transmitter actions in the regulation of V–SVZ neurogenesis.
4.3. Antidepressant drug actions in neurogenic regions
Given the inﬂuence of neurotransmitters on NSC function,
perhaps it is not surprising that antidepressant drugs can pre-
ferentially enhance neurogenesis in both the hippocampus and V–
SVZ. In hippocampus, selective serotonin reuptake inhibitors
(SSRIs), atypical antidepressants, selective norepinephrine re-
uptake inhibitors, monoamine oxidase inhibitors (MAOIs), and
tricyclic antidepressants all have been shown to increase neuro-
genesis in chronically treated animals (Malberg, 2004). For ex-
ample, the commonly used SSRI ﬂuoxetine is effective at produ-
cing an increase in hippocampal neurogenesis if treatment is
continuous for at least 14 days (Malberg, 2004). Interestingly,
electroconvulsive shock therapy (ECT), often used as a last line of
treatment against depressive disorders resistant to pharmacolo-
gical treatment, is also a potent inducer of neural stem cell pro-
liferation (Madsen et al., 2000).
It has been established that neurogenesis in the hippocampus
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antidepressant drugs, and that ablation of neurogenesis also pre-
vents behavioral improvements in animals being treated with
antidepressants (Santarelli et al., 2003). Reports on the necessity of
neurogenesis in effective treatment of mood disorders are not
surprising given the changes that take place in the hippocampus of
patients with depression or other affective disorders. Cognitive
deﬁcits, mood dysregulation, and declines in hippocampal volume
have all been correlated with mental disorders that display de-
creased neurogenesis, such as major depression, post-traumatic
stress disorder, schizophrenia, and Alzheimer’s disease (Bremner
et al., 1995; Bremner, 2001; DeCarolis and Eisch, 2010). Interest-
ingly, in Huntington’s disease, in which patients exhibit early signs
of cognitive distress, neurogenesis appears to decline pre-
ferentially in the striatum of humans (Ernst et al., 2014). Given the
underlying structural and cognitive deﬁcits in these mental dis-
orders, targeting neurogenesis directly as a therapeutic interven-
tion may lead to improved patient outcomes in future mental
health treatment paradigms.
The effects of antidepressant treatments are somewhat differ-
ent in the V–SVZ, where it has been reported that chronic ﬂuox-
etine alone decreases neurogenesis (Ohira and Miyakawa, 2011).
However, if the antidepressant treatment is given in conjunction
with corticosterone or chronic stress, which both decrease neu-
rogenesis and are major contributors to the development of mood
disorders, then antidepressant drugs actually reverse this decline
in neurogenesis (Hitoshi et al., 2007; Lau et al., 2007). Further,
antidepressant treatment following stroke, which increases neu-
rogenesis, can enhance proliferation of neural stem cells and im-
prove their migration toward sites of brain damage, but does not
enhance survival, differentiation, or behavioral outcomes in either
hippocampus or V–SVZ (Sun et al., 2015).5. Neurogenesis in humans
The discovery of neurogenesis in the human adult and the re-
generative capacity of neural stem cells has spurred interest in
designing novel therapies for conditions such as stroke, traumatic
brain injury, and neurodegenerative diseases. However, many
studies on NSCs employ rodent models and little is known about
adult neurogenesis in humans. Neurogenesis in the adult human
SGZ was ﬁrst demonstrated in the late 1990s by Eriksson and
coworkers (Eriksson et al., 1998). In this study, terminally ill cancer
patients were injected with the nucleotide analog bromodeox-
yuridine (BrdU) for diagnostic purposes during their cancer
treatment. Immunohistochemical analysis of postmortem brain
samples revealed BrdU incorporation within the DNA of dividing
cells of the hippocampus, which appear morphologically indis-
tinguishable from adult-born hippocampal neurons observed in
rodent models. Ethical concerns prohibit further studies such as
this one in terminally ill human subjects, but the strong evidence
of adult hippocampal neurogenesis gained from this patient po-
pulation was an invaluable contribution to the scientiﬁc
community.
A later study provided additional direct evidence of adult hip-
pocampal neurogenesis in humans. Nuclear bomb testing during
the Cold War produced elevated levels of 14C in the atmosphere,
which are mirrored in the 14C incorporation into the human body
(Harkness, 1972). Levels of 14C have been declining since testing in
the 1950s, but are still detectable and correlate with levels in
human tissue. Spalding and colleagues found that postmortem
brain samples probed for 14C levels in the hippocampus revealed
that adult neurogenesis does occur, at least into the ﬁfth decade of
life, in this brain region (Spalding et al., 2013). Further, neuro-
genesis is restricted to a subpopulation of cells in the hippocampusthat is subjected to turnover throughout life. Speciﬁcally, the
dentate gyrus of the hippocampus is the location of high cell
turnover, according to 14C measurements taken in aged tissue.
However, there is still a net loss in neurons in the dentate gyrus
throughout life, indicating that continued neurogenesis through-
out adulthood delays, but does not arrest, neuronal volume loss
with age.
Investigations in human V–SVZ and olfactory bulb revealed a
cytoarchitecturally distinct V–SVZ niche organization and neuro-
blast migration compared to rodents (Bergmann et al., 2012; Ernst
et al., 2014; Sanai et al., 2011). In humans, the V–SVZ displays a
dense ribbon of astrocytes after a subependymal gap (Sanai et al.,
2004). These astrocytes show multipotency in vitro and can gen-
erate neurons, astrocytes and oligodendrocytes (Sanai et al., 2011).
Although these putative neural stem cells display strong germinal
capacity in vitro, their migratory route differs between rodents
and humans. Early work by Sanai and colleagues revealed that
neurogenesis in the olfactory bulb is virtually absent in human
adult tissue (Sanai et al., 2004). More recent work has revealed
that olfactory neurogenesis does occur in humans, but only in
infants up to 18 months of age. The level of olfactory neurogenesis
declines dramatically by 24 months of age and is virtually absent
in adult tissue (Sanai et al., 2011). In support of these studies, re-
cent studies estimated cell turnover predicted to be only 1% of
human olfactory bulb cells across a 100 year lifespan using 14C
dating (Bergmann et al., 2012). 14C dating, along with other his-
tological evidence, shows that instead of giving rise to new neu-
rons in the olfactory bulb, neuroblasts from the V–SVZ migrate to
the striatum in humans (Ernst et al., 2014). This difference in NSC
migration between rodents and humans suggests the presence of a
functionally divergent mechanism for V–SVZ neurogenesis across
species. The striatum is commonly associated with motor function,
but recently it has been identiﬁed as necessary for cognitive
ﬂexibility, as evolutionary expansion of this region correlates with
an increase in cognitive function and ability in modern humans
(Ernst and Frisen, 2015). Carbon dating of two different neuronal
populations in the striatum of humans identiﬁed postnatal turn-
over of interneurons but not of medium spiny neurons, suggesting
progenitors from human V–SVZs contribute to the population of
interneurons in the striatum. However, recent work has demon-
strated that subpopulations of astrocytes in the striatal tissue can
give rise to new neurons in this region, suggesting that the stria-
tum may have an inherent capacity to regenerate neurons in-
dependent of the neighboring neurogenic cells in the V–SVZ
(Magnusson et al., 2014). Regardless of the NSC source, discovery
of striatum-speciﬁc neuronal turnover is of particular interest in
the study of neurodegenerative diseases with prominent striatal
involvement, such as Huntington’s disease. Some studies suggest
cell death in the striatum (as in the case of Huntington’s disease)
induces proliferation and thickening of the human V–SVZ, in-
stigating migration to the striatum through the caudate nucleus
(Curtis et al., 2007). Interestingly, carbon dating indicates a de-
crease in new neurons in the striatum of Huntington’s disease
patients when compared to age-matched healthy subjects (Ernst
et al., 2014), suggesting that this increase in proliferation does not
compensate for neuronal loss.
In humans, neurogenic regions receive similar innervation by
monoaminergic projections as observed in rodents, however there
are no reports on how NSCs in the SGZ and SVZ respond to neu-
rotransmitter signaling in the human brain. It is well established
that SGZ neurogenesis increases in response to antidepressant
treatment in animal models (Santarelli et al., 2003). Given the
highly conserved nature of neurotransmitter signaling in higher
mammals, it is reasonable to presume that similar effects on NSC
proliferation and migration may eventually be observed in human
neurogenic regions. Neurotransmitters can also inﬂuence growth
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neurogenesis (Hagg, 2009). Future advances in our ability to study
neurotransmission and neurogenesis in vivo may eventually
broaden our understanding of neurogenesis regulation by neuro-
transmitters in the human brain. For now, animal models are
providing the ﬁrst answers to these questions on neurotransmitter
regulation of NSCs.6. Adult human neurogenesis and psychiatric disorders
The functional implications of adult human hippocampal neu-
rogenesis remain unclear. It is thought that neurogenesis in hip-
pocampus is particularly important in memory formation and
consolidation, and dysfunctional neurogenic patterns are likely
involved in mood and psychiatric disorders. For example, in a
postmortem examination of hippocampal tissue from schizo-
phrenic patients, it was found that there is a dramatic decrease in
the number of proliferating cells in the SGZ (Allen et al., 2015).
Stress and depression contribute to decreased neurogenesis, and
antidepressant treatment has been shown to reverse this loss of
hippocampal neurogenesis (Mahar et al., 2014). Future work will
clarify the connections between neurogenesis and psychiatric
disorders, and may lead to the development of targeted neuro-
genesis therapies for mental illnesses.
Adult neurogenesis in the human V–SVZ is increasingly re-
cognized as a potential player in the development of psychiatric
and cognitive disorders. Recent attention has been given to the
role of the striatum in schizophrenia, where dopamine hyper-
activity is thought to contribute to the pathology of schizophrenia
(Simpson et al., 2010). Several reports have suggested that in-
creased adult neurogenesis in the V–SVZ may alleviate symptoms
of schizophrenia by targeting dopamine signaling at NSCs (Inta
et al., 2012). Given the evidence indicating that progenitors from
the V–SVZ migrate to the striatum in humans, it is plausible to
speculate that alterations in V–SVZ neurogenic activity may con-
tribute to the pathology of schizophrenia in humans. A more
thorough understanding of V–SVZ neurogenesis and the migratory
capacity of progenitors to the striatum in humans may be helpful
in harnessing the regenerative capacity of NSCs to treat neurode-
generative and psychiatric diseases in humans.7. Conclusions and future perspectives
The discovery of the remarkable process of adult neurogenesis
has revolutionized our understanding of the brain’s response to
disease and damage. The changes that occur in neurogenic cell
populations in response to stress, psychiatric disorders, and in the
early stages of neurodegenerative disease indicate that neural
stem cells may hold therapeutic potential for treatment of these
pathologies. Evidence of neural stem cell responsiveness to drugs
used in treating psychiatric disorders further supports this idea.
Neurogenesis in the SGZ has been shown to be necessary for ef-
fective treatment of mood and psychiatric disorders, while the V–
SVZ is not typically linked to psychiatric dysfunction. However, the
recent evidence of V–SVZ neural stem cell control, in part by
monoamines involved in mood, cognitive, and neurodegenerative
disorders, indicates that neurogenesis in this region may also play
a role in maintenance of normal mood and cognitive regulation. In
humans, it is likely that the ultimate fate of V–SVZ neural stem
cells is integration into the striatal tissue rather than the olfactory
bulb, as seen in rodents. The involvement of the human V–SVZ and
striatum in adult neurogenesis has revised our understanding of
neurodegenerative diseases that have an early cognitive or mood
component. Our knowledge of adult neurogenesis and neural stemcell regulation has grown exponentially over the last two decades,
however we still lack a complete understanding of the neurogenic
process in the human brain. Further work on understanding hu-
man adult neurogenesis may reveal a critical role of the V–SVZ and
striatum in mood, cognition, and neurodegeneration.Author information
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